CA2603280C - Procede pour immobiliser des molecules mediatrices sur des materiaux d'implants inorganiques etmetalliques - Google Patents

Procede pour immobiliser des molecules mediatrices sur des materiaux d'implants inorganiques etmetalliques Download PDF

Info

Publication number: CA2603280C
Authority: CA; Canada
Prior art keywords: molecule; implant material; implant; mediator; bmp
Prior art date: 1997-11-24
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Lifetime

Application number

CA2603280A

Other languages

English (en)

Other versions

CA2603280A1 (fr

Inventor

Herbert Peter Jennissen

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Morphoplant GmbH

Original Assignee

Morphoplant GmbH

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-11-24

Filing date

1998-11-24

Publication date

2012-08-14

1998-11-24 Application filed by Morphoplant GmbH filed Critical Morphoplant GmbH

1998-11-24 Priority claimed from CA002311445A external-priority patent/CA2311445C/fr

1999-06-03 Publication of CA2603280A1 publication Critical patent/CA2603280A1/fr

2012-08-14 Application granted granted Critical

2012-08-14 Publication of CA2603280C publication Critical patent/CA2603280C/fr

2018-11-24 Anticipated expiration legal-status Critical

Status Expired - Lifetime legal-status Critical Current

Links

239000007943 implant Substances 0.000 title claims abstract description 83
238000000034 method Methods 0.000 title claims abstract description 55
239000000463 material Substances 0.000 title claims abstract description 45
229910052751 metal Inorganic materials 0.000 title claims abstract description 33
239000002184 metal Substances 0.000 title claims abstract description 33
230000003100 immobilizing effect Effects 0.000 title claims abstract description 9
229910010293 ceramic material Inorganic materials 0.000 claims abstract description 12
125000000524 functional group Chemical group 0.000 claims abstract description 9
229910001092 metal group alloy Inorganic materials 0.000 claims abstract description 8
150000001875 compounds Chemical class 0.000 claims abstract description 6
230000009257 reactivity Effects 0.000 claims abstract 4
230000003213 activating effect Effects 0.000 claims abstract 3
RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 claims description 50
102000004169 proteins and genes Human genes 0.000 claims description 45
108090000623 proteins and genes Proteins 0.000 claims description 45
239000010936 titanium Substances 0.000 claims description 37
229910052719 titanium Inorganic materials 0.000 claims description 36
125000006850 spacer group Chemical group 0.000 claims description 28
XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 claims description 24
229910052588 hydroxylapatite Inorganic materials 0.000 claims description 22
229920000936 Agarose Polymers 0.000 claims description 21
210000000988 bone and bone Anatomy 0.000 claims description 16
108090000848 Ubiquitin Proteins 0.000 claims description 15
102000044159 Ubiquitin Human genes 0.000 claims description 15
238000011068 loading method Methods 0.000 claims description 7
108010049931 Bone Morphogenetic Protein 2 Proteins 0.000 claims description 6
102100024506 Bone morphogenetic protein 2 Human genes 0.000 claims description 6
229910001069 Ti alloy Inorganic materials 0.000 claims description 5
229910001220 stainless steel Inorganic materials 0.000 claims description 5
239000004411 aluminium Substances 0.000 claims description 4
229910052782 aluminium Inorganic materials 0.000 claims description 4
XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 claims description 4
230000000921 morphogenic effect Effects 0.000 claims description 4
239000010935 stainless steel Substances 0.000 claims description 4
108010049870 Bone Morphogenetic Protein 7 Proteins 0.000 claims description 3
102100022544 Bone morphogenetic protein 7 Human genes 0.000 claims description 3
239000003242 anti bacterial agent Substances 0.000 claims description 3
230000003115 biocidal effect Effects 0.000 claims 2
CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 57
235000018102 proteins Nutrition 0.000 description 43
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 39
238000010168 coupling process Methods 0.000 description 37
238000006243 chemical reaction Methods 0.000 description 36
238000005859 coupling reaction Methods 0.000 description 36
230000008878 coupling Effects 0.000 description 35
YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 33
239000000243 solution Substances 0.000 description 28
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 27
DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 26
239000010410 layer Substances 0.000 description 19
239000011248 coating agent Substances 0.000 description 15
238000000576 coating method Methods 0.000 description 15
230000004913 activation Effects 0.000 description 14
210000004027 cell Anatomy 0.000 description 14
238000001179 sorption measurement Methods 0.000 description 12
238000005406 washing Methods 0.000 description 12
PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 description 11
239000012153 distilled water Substances 0.000 description 11
238000004519 manufacturing process Methods 0.000 description 11
QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 11
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 10
239000000872 buffer Substances 0.000 description 10
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
ZPZDIFSPRVHGIF-UHFFFAOYSA-N 3-aminopropylsilicon Chemical compound NCCC[Si] ZPZDIFSPRVHGIF-UHFFFAOYSA-N 0.000 description 8
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 8
230000008468 bone growth Effects 0.000 description 8
238000002474 experimental method Methods 0.000 description 8
JQWHASGSAFIOCM-UHFFFAOYSA-M sodium periodate Chemical compound [Na+].[O-]I(=O)(=O)=O JQWHASGSAFIOCM-UHFFFAOYSA-M 0.000 description 8
239000000126 substance Substances 0.000 description 8
230000008859 change Effects 0.000 description 7
239000003102 growth factor Substances 0.000 description 7
229910044991 metal oxide Inorganic materials 0.000 description 7
239000000843 powder Substances 0.000 description 7
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
150000004706 metal oxides Chemical class 0.000 description 6
239000008363 phosphate buffer Substances 0.000 description 6
238000010992 reflux Methods 0.000 description 6
PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 5
GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 5
229910021538 borax Inorganic materials 0.000 description 5
239000007795 chemical reaction product Substances 0.000 description 5
229910017604 nitric acid Inorganic materials 0.000 description 5
229910052757 nitrogen Inorganic materials 0.000 description 5
VSIIXMUUUJUKCM-UHFFFAOYSA-D pentacalcium;fluoride;triphosphate Chemical compound [F-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O VSIIXMUUUJUKCM-UHFFFAOYSA-D 0.000 description 5
230000035755 proliferation Effects 0.000 description 5
235000010339 sodium tetraborate Nutrition 0.000 description 5
210000001519 tissue Anatomy 0.000 description 5
BSVBQGMMJUBVOD-UHFFFAOYSA-N trisodium borate Chemical compound [Na+].[Na+].[Na+].[O-]B([O-])[O-] BSVBQGMMJUBVOD-UHFFFAOYSA-N 0.000 description 5
SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 4
DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
229910052586 apatite Inorganic materials 0.000 description 4
239000012620 biological material Substances 0.000 description 4
230000015572 biosynthetic process Effects 0.000 description 4
229960000587 glutaral Drugs 0.000 description 4
-1 glutaric dialdehyde Chemical compound 0.000 description 4
230000035876 healing Effects 0.000 description 4
239000005556 hormone Substances 0.000 description 4
229940088597 hormone Drugs 0.000 description 4
238000002513 implantation Methods 0.000 description 4
238000012986 modification Methods 0.000 description 4
210000000963 osteoblast Anatomy 0.000 description 4
230000003647 oxidation Effects 0.000 description 4
238000007254 oxidation reaction Methods 0.000 description 4
239000000047 product Substances 0.000 description 4
230000009467 reduction Effects 0.000 description 4
229910000077 silane Inorganic materials 0.000 description 4
238000003756 stirring Methods 0.000 description 4
GWEVSGVZZGPLCZ-UHFFFAOYSA-N titanium dioxide Inorganic materials O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 4
BPSIOYPQMFLKFR-UHFFFAOYSA-N trimethoxy-[3-(oxiran-2-ylmethoxy)propyl]silane Chemical compound CO[Si](OC)(OC)CCCOCC1CO1 BPSIOYPQMFLKFR-UHFFFAOYSA-N 0.000 description 4
FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 description 3
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
PNEYBMLMFCGWSK-UHFFFAOYSA-N Alumina Chemical compound [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 3
HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 3
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
102000008946 Fibrinogen Human genes 0.000 description 3
108010049003 Fibrinogen Proteins 0.000 description 3
BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 description 3
125000003277 amino group Chemical group 0.000 description 3
210000002449 bone cell Anatomy 0.000 description 3
239000007853 buffer solution Substances 0.000 description 3
238000004113 cell culture Methods 0.000 description 3
ATDGTVJJHBUTRL-UHFFFAOYSA-N cyanogen bromide Chemical compound BrC#N ATDGTVJJHBUTRL-UHFFFAOYSA-N 0.000 description 3
230000004069 differentiation Effects 0.000 description 3
229940012952 fibrinogen Drugs 0.000 description 3
239000000499 gel Substances 0.000 description 3
238000011534 incubation Methods 0.000 description 3
239000011261 inert gas Substances 0.000 description 3
238000003780 insertion Methods 0.000 description 3
230000037431 insertion Effects 0.000 description 3
230000003993 interaction Effects 0.000 description 3
239000000203 mixture Substances 0.000 description 3
229910052759 nickel Inorganic materials 0.000 description 3
150000004756 silanes Chemical class 0.000 description 3
239000011780 sodium chloride Substances 0.000 description 3
239000012064 sodium phosphate buffer Substances 0.000 description 3
238000006467 substitution reaction Methods 0.000 description 3
239000000758 substrate Substances 0.000 description 3
VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 2
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
101000762366 Homo sapiens Bone morphogenetic protein 2 Proteins 0.000 description 2
108010058683 Immobilized Proteins Proteins 0.000 description 2
NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
WGLPBDUCMAPZCE-UHFFFAOYSA-N Trioxochromium Chemical compound O=[Cr](=O)=O WGLPBDUCMAPZCE-UHFFFAOYSA-N 0.000 description 2
239000002253 acid Substances 0.000 description 2
239000011543 agarose gel Substances 0.000 description 2
238000004873 anchoring Methods 0.000 description 2
239000000919 ceramic Substances 0.000 description 2
229960001701 chloroform Drugs 0.000 description 2
210000004351 coronary vessel Anatomy 0.000 description 2
239000003599 detergent Substances 0.000 description 2
238000011161 development Methods 0.000 description 2
230000018109 developmental process Effects 0.000 description 2
CGMRCMMOCQYHAD-UHFFFAOYSA-J dicalcium hydroxide phosphate Chemical compound [OH-].[Ca++].[Ca++].[O-]P([O-])([O-])=O CGMRCMMOCQYHAD-UHFFFAOYSA-J 0.000 description 2
230000000694 effects Effects 0.000 description 2
229940071106 ethylenediaminetetraacetate Drugs 0.000 description 2
102000045896 human BMP2 Human genes 0.000 description 2
230000010354 integration Effects 0.000 description 2
239000007769 metal material Substances 0.000 description 2
230000007935 neutral effect Effects 0.000 description 2
125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 2
230000011164 ossification Effects 0.000 description 2
239000012071 phase Substances 0.000 description 2
235000011007 phosphoric acid Nutrition 0.000 description 2
230000004962 physiological condition Effects 0.000 description 2
229920000642 polymer Polymers 0.000 description 2
239000002243 precursor Substances 0.000 description 2
230000002265 prevention Effects 0.000 description 2
230000008569 process Effects 0.000 description 2
230000011514 reflex Effects 0.000 description 2
230000002940 repellent Effects 0.000 description 2
239000005871 repellent Substances 0.000 description 2
238000000926 separation method Methods 0.000 description 2
238000002444 silanisation Methods 0.000 description 2
229910000162 sodium phosphate Inorganic materials 0.000 description 2
230000000638 stimulation Effects 0.000 description 2
KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
239000006228 supernatant Substances 0.000 description 2
239000000725 suspension Substances 0.000 description 2
238000012360 testing method Methods 0.000 description 2
238000003828 vacuum filtration Methods 0.000 description 2
WYTZZXDRDKSJID-UHFFFAOYSA-N (3-aminopropyl)triethoxysilane Chemical compound CCO[Si](OCC)(OCC)CCCN WYTZZXDRDKSJID-UHFFFAOYSA-N 0.000 description 1
SKDHHIUENRGTHK-UHFFFAOYSA-N 4-nitrobenzoyl chloride Chemical compound [O-][N+](=O)C1=CC=C(C(Cl)=O)C=C1 SKDHHIUENRGTHK-UHFFFAOYSA-N 0.000 description 1
DWSWVFGBDZBQEF-UHFFFAOYSA-N 4-triethylsilyloxypentan-1-amine Chemical compound CC[Si](CC)(CC)OC(C)CCCN DWSWVFGBDZBQEF-UHFFFAOYSA-N 0.000 description 1
JPLATTLXZFUKRQ-UHFFFAOYSA-N Agarobiose Natural products OCC1OC(OC2C(O)COC2C(O)C=O)C(O)C(O)C1O JPLATTLXZFUKRQ-UHFFFAOYSA-N 0.000 description 1
102000002260 Alkaline Phosphatase Human genes 0.000 description 1
108020004774 Alkaline Phosphatase Proteins 0.000 description 1
108010049955 Bone Morphogenetic Protein 4 Proteins 0.000 description 1
108010049976 Bone Morphogenetic Protein 5 Proteins 0.000 description 1
108010049974 Bone Morphogenetic Protein 6 Proteins 0.000 description 1
102100024505 Bone morphogenetic protein 4 Human genes 0.000 description 1
102100022526 Bone morphogenetic protein 5 Human genes 0.000 description 1
102100022525 Bone morphogenetic protein 6 Human genes 0.000 description 1
241000283690 Bos taurus Species 0.000 description 1
101100017533 Caenorhabditis elegans hmp-2 gene Proteins 0.000 description 1
BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
241000282472 Canis lupus familiaris Species 0.000 description 1
241000700199 Cavia porcellus Species 0.000 description 1
241000282693 Cercopithecidae Species 0.000 description 1
229910000531 Co alloy Inorganic materials 0.000 description 1
102000008186 Collagen Human genes 0.000 description 1
108010035532 Collagen Proteins 0.000 description 1
102000004127 Cytokines Human genes 0.000 description 1
108090000695 Cytokines Proteins 0.000 description 1
ZNZYKNKBJPZETN-WELNAUFTSA-N Dialdehyde 11678 Chemical compound N1C2=CC=CC=C2C2=C1[C@H](C[C@H](/C(=C/O)C(=O)OC)[C@@H](C=C)C=O)NCC2 ZNZYKNKBJPZETN-WELNAUFTSA-N 0.000 description 1
206010058314 Dysplasia Diseases 0.000 description 1
239000004593 Epoxy Substances 0.000 description 1
108010042653 IgA receptor Proteins 0.000 description 1
206010023204 Joint dislocation Diseases 0.000 description 1
QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
FDWRVIIRVOFADE-UHFFFAOYSA-N NCCC[SiH2][Ti] Chemical compound NCCC[SiH2][Ti] FDWRVIIRVOFADE-UHFFFAOYSA-N 0.000 description 1
241000283973 Oryctolagus cuniculus Species 0.000 description 1
108090000573 Osteocalcin Proteins 0.000 description 1
102000004067 Osteocalcin Human genes 0.000 description 1
102000004264 Osteopontin Human genes 0.000 description 1
108010081689 Osteopontin Proteins 0.000 description 1
241000206607 Porphyra umbilicalis Species 0.000 description 1
102100034014 Prolyl 3-hydroxylase 3 Human genes 0.000 description 1
108010029485 Protein Isoforms Proteins 0.000 description 1
102000001708 Protein Isoforms Human genes 0.000 description 1
101710148703 Protein Smp Proteins 0.000 description 1
241000700159 Rattus Species 0.000 description 1
108091006629 SLC13A2 Proteins 0.000 description 1
239000002262 Schiff base Substances 0.000 description 1
150000004753 Schiff bases Chemical class 0.000 description 1
229920002684 Sepharose Polymers 0.000 description 1
239000004809 Teflon Substances 0.000 description 1
229920006362 Teflon® Polymers 0.000 description 1
102000004887 Transforming Growth Factor beta Human genes 0.000 description 1
108090001012 Transforming Growth Factor beta Proteins 0.000 description 1
239000007983 Tris buffer Substances 0.000 description 1
QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
229910000756 V alloy Inorganic materials 0.000 description 1
235000001014 amino acid Nutrition 0.000 description 1
150000001413 amino acids Chemical class 0.000 description 1
238000004458 analytical method Methods 0.000 description 1
229940088710 antibiotic agent Drugs 0.000 description 1
150000004982 aromatic amines Chemical class 0.000 description 1
PASDCCFISLVPSO-UHFFFAOYSA-N benzoyl chloride Chemical group ClC(=O)C1=CC=CC=C1 PASDCCFISLVPSO-UHFFFAOYSA-N 0.000 description 1
239000011230 binding agent Substances 0.000 description 1
230000004071 biological effect Effects 0.000 description 1
230000033558 biomineral tissue development Effects 0.000 description 1
230000000903 blocking effect Effects 0.000 description 1
238000009835 boiling Methods 0.000 description 1
229910001424 calcium ion Inorganic materials 0.000 description 1
150000001718 carbodiimides Chemical class 0.000 description 1
125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
150000007942 carboxylates Chemical group 0.000 description 1
230000003197 catalytic effect Effects 0.000 description 1
230000001413 cellular effect Effects 0.000 description 1
230000003399 chemotactic effect Effects 0.000 description 1
230000035605 chemotaxis Effects 0.000 description 1
VDQQXEISLMTGAB-UHFFFAOYSA-N chloramine T Chemical compound [Na+].CC1=CC=C(S(=O)(=O)[N-]Cl)C=C1 VDQQXEISLMTGAB-UHFFFAOYSA-N 0.000 description 1
IJOOHPMOJXWVHK-UHFFFAOYSA-N chlorotrimethylsilane Chemical class C[Si](C)(C)Cl IJOOHPMOJXWVHK-UHFFFAOYSA-N 0.000 description 1
210000001612 chondrocyte Anatomy 0.000 description 1
229920001436 collagen Polymers 0.000 description 1
230000000052 comparative effect Effects 0.000 description 1
239000007822 coupling agent Substances 0.000 description 1
230000002950 deficient Effects 0.000 description 1
238000010586 diagram Methods 0.000 description 1
229960004132 diethyl ether Drugs 0.000 description 1
238000001035 drying Methods 0.000 description 1
230000013020 embryo development Effects 0.000 description 1
238000002149 energy-dispersive X-ray emission spectroscopy Methods 0.000 description 1
DQYBDCGIPTYXML-UHFFFAOYSA-N ethoxyethane;hydrate Chemical compound O.CCOCC DQYBDCGIPTYXML-UHFFFAOYSA-N 0.000 description 1
210000002950 fibroblast Anatomy 0.000 description 1
210000000630 fibrocyte Anatomy 0.000 description 1
239000012634 fragment Substances 0.000 description 1
239000007789 gas Substances 0.000 description 1
238000010353 genetic engineering Methods 0.000 description 1
230000012010 growth Effects 0.000 description 1
230000036541 health Effects 0.000 description 1
108091008039 hormone receptors Proteins 0.000 description 1
230000002209 hydrophobic effect Effects 0.000 description 1
125000004356 hydroxy functional group Chemical group O* 0.000 description 1
125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
230000033444 hydroxylation Effects 0.000 description 1
238000005805 hydroxylation reaction Methods 0.000 description 1
239000012535 impurity Substances 0.000 description 1
238000000338 in vitro Methods 0.000 description 1
230000005764 inhibitory process Effects 0.000 description 1
238000011835 investigation Methods 0.000 description 1
230000002427 irreversible effect Effects 0.000 description 1
150000002540 isothiocyanates Chemical class 0.000 description 1
239000007791 liquid phase Substances 0.000 description 1
210000002540 macrophage Anatomy 0.000 description 1
206010025482 malaise Diseases 0.000 description 1
238000005259 measurement Methods 0.000 description 1
230000007246 mechanism Effects 0.000 description 1
150000002739 metals Chemical class 0.000 description 1
POPACFLNWGUDSR-UHFFFAOYSA-N methoxy(trimethyl)silane Chemical compound CO[Si](C)(C)C POPACFLNWGUDSR-UHFFFAOYSA-N 0.000 description 1
230000011278 mitosis Effects 0.000 description 1
230000004001 molecular interaction Effects 0.000 description 1
235000019799 monosodium phosphate Nutrition 0.000 description 1
210000000663 muscle cell Anatomy 0.000 description 1
210000003098 myoblast Anatomy 0.000 description 1
GDONVDKTEQXRAY-UHFFFAOYSA-N n'-cyclohexyl-n-(2-morpholin-4-ylethyl)methanediimine;4-(methoxymethyl)benzenesulfonic acid Chemical compound COCC1=CC=C(S(O)(=O)=O)C=C1.C1CCCCC1N=C=NCCN1CCOCC1 GDONVDKTEQXRAY-UHFFFAOYSA-N 0.000 description 1
230000005305 organ development Effects 0.000 description 1
239000003960 organic solvent Substances 0.000 description 1
210000004409 osteocyte Anatomy 0.000 description 1
230000002138 osteoinductive effect Effects 0.000 description 1
239000002245 particle Substances 0.000 description 1
239000002861 polymer material Substances 0.000 description 1
239000011148 porous material Substances 0.000 description 1
239000008057 potassium phosphate buffer Substances 0.000 description 1
238000002360 preparation method Methods 0.000 description 1
150000003141 primary amines Chemical class 0.000 description 1
125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
230000001681 protective effect Effects 0.000 description 1
230000002797 proteolythic effect Effects 0.000 description 1
230000002285 radioactive effect Effects 0.000 description 1
108020003175 receptors Proteins 0.000 description 1
238000001055 reflectance spectroscopy Methods 0.000 description 1
230000029219 regulation of pH Effects 0.000 description 1
208000037803 restenosis Diseases 0.000 description 1
239000000523 sample Substances 0.000 description 1
BEOOHQFXGBMRKU-UHFFFAOYSA-N sodium cyanoborohydride Chemical compound [Na+].[B-]C#N BEOOHQFXGBMRKU-UHFFFAOYSA-N 0.000 description 1
AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 1
235000019345 sodium thiosulphate Nutrition 0.000 description 1
230000007480 spreading Effects 0.000 description 1
238000003892 spreading Methods 0.000 description 1
238000010561 standard procedure Methods 0.000 description 1
239000001384 succinic acid Substances 0.000 description 1
239000002344 surface layer Substances 0.000 description 1
239000004094 surface-active agent Substances 0.000 description 1
238000003786 synthesis reaction Methods 0.000 description 1
229920002994 synthetic fiber Polymers 0.000 description 1
229920001059 synthetic polymer Polymers 0.000 description 1
ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 description 1
230000001225 therapeutic effect Effects 0.000 description 1
230000009772 tissue formation Effects 0.000 description 1
150000003608 titanium Chemical class 0.000 description 1
239000004408 titanium dioxide Substances 0.000 description 1
230000001988 toxicity Effects 0.000 description 1
231100000419 toxicity Toxicity 0.000 description 1
150000003918 triazines Chemical class 0.000 description 1
230000001960 triggered effect Effects 0.000 description 1
GPPXJZIENCGNKB-UHFFFAOYSA-N vanadium Chemical compound [V]#[V] GPPXJZIENCGNKB-UHFFFAOYSA-N 0.000 description 1
210000004509 vascular smooth muscle cell Anatomy 0.000 description 1

Landscapes

Materials For Medical Uses (AREA)

CA2603280A 1997-11-24 1998-11-24 Procede pour immobiliser des molecules mediatrices sur des materiaux d'implants inorganiques etmetalliques Expired - Lifetime CA2603280C (fr)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
DE19752032.4		1997-11-24
DE19752032		1997-11-24
CA002311445A CA2311445C (fr)	1997-11-24	1998-11-24	Procede pour immobiliser des molecules mediatrices sur des materiaux d'implants inorganiques et metalliques

Related Parent Applications (1)

Application Number	Title	Priority Date	Filing Date
CA002311445A Division CA2311445C (fr)	1997-11-24	1998-11-24	Procede pour immobiliser des molecules mediatrices sur des materiaux d'implants inorganiques et metalliques

Publications (2)

Publication Number	Publication Date
CA2603280A1 CA2603280A1 (fr)	1999-06-03
CA2603280C true CA2603280C (fr)	2012-08-14

Family

ID=38829384

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA2603280A Expired - Lifetime CA2603280C (fr)	1997-11-24	1998-11-24	Procede pour immobiliser des molecules mediatrices sur des materiaux d'implants inorganiques etmetalliques

Country Status (1)

Country	Link
CA (1)	CA2603280C (fr)

1998
- 1998-11-24 CA CA2603280A patent/CA2603280C/fr not_active Expired - Lifetime

Also Published As

Publication number	Publication date
CA2603280A1 (fr)	1999-06-03

Publication	Publication Date	Title
AU749139B2 (en)	2002-06-20	Method for immobilizing mediator molecule on inorganic and metal implant material
US9095640B2 (en)	2015-08-04	Bioactive implant and method of use
Crouzier et al.	2011	The performance of BMP-2 loaded TCP/HAP porous ceramics with a polyelectrolyte multilayer film coating
Lee et al.	2014	A simultaneous process of 3D magnesium phosphate scaffold fabrication and bioactive substance loading for hard tissue regeneration
Nanci et al.	1998	Chemical modification of titanium surfaces for covalent attachment of biological molecules
TW448051B (en)	2001-08-01	A controlled-release carrier comprising bioactive silica-based glass and biologically active molecules incorporated within said silica-based glass
Luong et al.	2006	Spatial control of protein within biomimetically nucleated mineral
CA2793181C (fr)	2019-04-16	Nanotubes et compositions associees
Xie et al.	2001	Effect of albumin on brushite transformation to hydroxyapatite
McLeod et al.	2006	XPS and bioactivity study of the bisphosphonate pamidronate adsorbed onto plasma sprayed hydroxyapatite coatings
AU2008320842B2 (en)	2011-09-22	Process for producing particles loaded with growth factors, and the particles obtained in this way
Spoerke et al.	2005	Synthesis of a poly (L-lysine)-calcium phosphate hybrid on titanium surfaces for enhanced bioactivity
Manzano et al.	2011	Comparison of the osteoblastic activity conferred on Si-doped hydroxyapatite scaffolds by different osteostatin coatings
CA2603280C (fr)	2012-08-14	Procede pour immobiliser des molecules mediatrices sur des materiaux d'implants inorganiques etmetalliques
Yu et al.	2009	Incorporation of bovine serum albumin into biomimetic coatings on titanium with high loading efficacy and its release behavior
AU771873B2 (en)	2004-04-01	Method for the application of an oxide layer on metallic implant materials
Wang et al.	2005	In vitro haemocompatibility and stability of two types of heparin-immobilized silicon surfaces
Aina et al.	2011	Novel bio-conjugate materials: soybean peroxidase immobilized on bioactive glasses containing Au nanoparticles
EP1880739B1 (fr)	2017-09-13	Procédé d'immobilisation de protéines sur des implants
CN111790004A (zh)	2020-10-20	一种通用型载药钙磷骨水泥多孔支架制备方法
KR20210124078A (ko)	2021-10-14	카테콜 및 바이오 실리카를 이용한 서방성 약물 전달체 및 이의 용도
Crouzier et al.	2011	Osteoinductive TCP/HAP porous ceramics loaded with BMP-2: Polyelectrolyte multilayer film coating versus direct adsorption
JP2847847B2 (ja)	1999-01-20	リン酸カルシウム―キチン複合膜の形成方法
PL201383B1 (pl)	2009-04-30	Sposób immobilizacji antybiotyków zawierających I-rzędowe grupy aminowe ze stałymi matrycami pokrytymi białkiem
HK1169338A1 (en)	2013-01-25	Multilayer protein films, methods of making, and drug delivery devices and biomedical implants employing the films

Legal Events

Date	Code	Title	Description
2007-10-10	EEER	Examination request